Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-13

Longevity Health Holdings, Inc. (XAGE) Stock Forecast Oct. 13, 2026

Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC

Follow Unlock full AI forecasts
Rating · 90D Neutral Total
90-day forecast Sign up free to reveal
30-day forecast Total
Rank in coverage Middle 30% of 5379 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $270K small-cap · #6 of 6 peers
Summary

Longevity Health Holdings, Inc. (XAGE) stock forecast summary

On Oct. 13, 2026, XAGE is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5379 stocks scored that day.

Longevity Health Holdings, Inc. is a small-cap company with a market capitalization of $270K. It ranks number 6 by market capitalization among the 6 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics issuers in our coverage with a current forecast.

A per-ticker accuracy statistic for XAGE is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, XAGE included.

Follow XAGE free
Price

XAGE price chart and AI forecast

XAGE
Cross-section · 2026-10-13

How XAGE ranks among 5379 stocks

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Longevity Health Holdings, Inc. (XAGE) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics peers listed below that report each metric.

Valuation & Market

MetricXAGEIndustry medianRank
Market Cap $270K $51.91B 6/6
EPS $-4.06 – –
Revenue/Share $0.68 – –

Profitability & Margins

MetricXAGEIndustry medianRank
ROA -647.0% – –
ROIC 67.9% – –
Gross Margin 59.0% 45.6% 1/5
Operating Margin -343.6% 16.9% 5/5
Net Margin -404.8% – –
EBT Margin -402.7% 15.3% 5/5
Tax Rate -0.5% – –

Financial Health

MetricXAGEIndustry medianRank
Current Ratio 0.07x – –
Quick Ratio 0.01x – –
Interest Coverage -336.3x 4.6x 5/5
Working Capital -$9M – –

Cash Flow

MetricXAGEIndustry medianRank
Operating Cash Flow -$2M $1.97B 5/5

Operational Efficiency

MetricXAGEIndustry medianRank
Asset Turnover 1.60x 0.69x 1/5
Receivables Turnover 86.3x – –
Inventory Turnover 1.1x – –
Fixed Assets Turnover 22.3x – –
Days Sales Outstanding 4 days – –
Days Inventory 320 days – –
Payables Period 2659 days – –
Cash Conversion Cycle -2335 days – –

Income Statement

MetricXAGEIndustry medianRank
Total Revenue $1M $6.23B 5/5
Operating Income -$5M $1.09B 5/5
Net Income -$6M – –
R&D Expense $490K – –
Cost of Goods Sold $690K $3.39B 5/5

Dividend & Shareholder Information

MetricXAGEIndustry medianRank
Shares Outstanding 2M – –
EPS Growth -3657.7% – –

Balance Sheet Highlights (USD millions)

Total Current Assets$710K67.0% of assets
Cash & Short-term Investments$40K3.8% of assets
Accounts Receivable$20K1.9% of assets
Inventory$610K57.5% of assets
Total Liabilities$10M919.8% of assets
Short-term Debt$5M
Quarterly Financial Reports

XAGE quarterly financials and insider trading

Industry Peers · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics

Longevity Health Holdings, Inc. (XAGE) industry peers

Companies classified under the same SEC industry code as Longevity Health Holdings, Inc. (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics): 6 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Total) Market Cap P/E Ratio P/B Ratio
XAGE Longevity Health Holdings, Inc. ▶ $270K – –
PG Procter & Gamble Co ▼ $355.73B 22.2x 6.6x
UL Unilever Plc ▼ $137.29B – –
ECL Ecolab Inc. ▼ $80.08B 37.8x 8.0x
CHD Church & Dwight Co Inc /De/ ▼ $23.75B 31.9x 5.5x
SCL Stepan Co ▼ $1.38B – 1.1x

Where XAGE sits on the market map

Industrial Applications and Services · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Explore the map →
News

Longevity Health Holdings, Inc. (XAGE) stock news

Loading...

FAQ

Longevity Health Holdings, Inc. (XAGE) stock forecast FAQ

What is the Longevity Health Holdings, Inc. (XAGE) stock forecast?

On Oct. 13, 2026, XAGE is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5379 stocks scored that day.

How accurate are Longevity Health Holdings, Inc. stock predictions?

A per-ticker accuracy statistic for XAGE is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Longevity Health Holdings, Inc. forecasts updated?

Longevity Health Holdings, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Which companies are Longevity Health Holdings, Inc.'s industry peers?

6 issuers in our coverage, XAGE included, share the SEC industry code Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics. The largest are: Procter & Gamble Co (PG), Unilever Plc (UL), Ecolab Inc. (ECL), Church & Dwight Co Inc /De/ (CHD), Stepan Co (SCL).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.